Legal Opinion
Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc.
Court of Appeals for the Federal Circuit
Decided May 1, 2017No. 2016-1284, 2016-1787PublishedCited by 27 opinions
1Opinion of the Court
DYK, Circuit Judge.
Helsinn Healthcare S.A. (“Helsinn”) is the owner of the four patents-in-suit di rected to intravenous formulations of palo-nosetron for reducing or reducing the likelihood of chemotherapy-induced nausea and vomiting (“CINV”).
Helsinn brought suit against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd. (collectively, “Teva”) alleging that the filing of Teva’s Abbreviated New Drug Application (“ANDA”) constituted an infringement of various claims of those patents. Teva defended, inter alia, on the ground that the asserted claims were invalid under the…
2Cases cited48 opinions
- Exxon Mobil Corp. v. Allapattah Services, Inc.Supreme Court of the United States · 2005
- Pfaff v. Wells Electronics, Inc.Supreme Court of the United States · 1998
- C.R. Bard, Inc. v. M3 Systems, Inc.Court of Appeals for the Federal Circuit · 1998
- Director, Office of Workers' Compensation Programs v. Perini North River AssociatesSupreme Court of the United States · 1983
- BG Group, PLC v. Republic of ArgentinaSupreme Court of the United States · 2014
43 more not listed; retrieve them via the Exa API.
3Cited by27 opinions
- Helsinn Healthcare S. A. v. Teva Pharmaceuticals USA, Inc.Supreme Court of the United States · 2019
- Barry v. Medtronic, Inc.Court of Appeals for the Federal Circuit · 2019
- Polara Engineering Inc v. Campbell CompanyCourt of Appeals for the Federal Circuit · 2018
- Gs Cleantech Corp. v. Adkins Energy LLCCourt of Appeals for the Federal Circuit · 2020
- Medicines Company v. Hospira, Inc.Court of Appeals for the Federal Circuit · 2018
22 more not listed; retrieve them via the Exa API.